Navigation Links
Home Oxygen Patients and Family Members Visit Capitol Hill to Ask Congress to Protect Medicare Home Oxygen Therapy Benefit
Date:7/17/2009

Patient Advocates, Medicare Beneficiaries Visit Capitol Hill to Urge Congress to Pass Medicare Home Oxygen Therapy Act, Oppose Additional Cuts to Oxygen Benefit

WASHINGTON, July 17 /PRNewswire-USNewswire/ -- Asking members of Congress to support patient-focused reform of the Medicare home oxygen therapy benefit, patients and family members with the National Emphysema/COPD Association (NECA), a national advocacy organization representing patients with chronic obstructive pulmonary disease (COPD) and other lung diseases, descended on Capitol Hill this week. Patients urged members of the U.S. House to support and pass the Medicare Home Oxygen Therapy Act of 2009 (H.R. 3220), which was recently introduced.

"Though it is extremely difficult for many users of home oxygen to travel, patients and their families feel strongly enough about home oxygen issues to visit Washington to share their personal stories with their legislators and describe how home oxygen improves quality of life for patients," said Barbara Rogers, President and CEO of NECA. "It is really exciting for us to be here during this transformational time in our nation's healthcare system and we hope our message is heard on Capitol Hill. By meeting with lawmakers and their staff, we want to educate them about home oxygen therapy, explain why there should be no additional cuts to the Medicare home oxygen benefit and ask them to support comprehensive benefit reform."

The Medicare Home Oxygen Therapy Act of 2009 establishes a standard set of patient services, including routine patient evaluations, patient monitoring, equipment training and maintenance and emergency services, all of which play a crucial role in ensuring oxygen users are receiving the medically appropriate level of oxygen that meets their needs and allows them to live safely and comfortably. By ensuring access to these services and important patient safeguards, this legislation recognizes that home oxygen is much more than a piece of oxygen equipment; it is a healthcare service that provides life-supporting oxygen, which enables patients to breathe.

Home oxygen users, family members and advocates oppose additional cuts to the home oxygen benefit, an essential Medicare benefit that serves 1.5 million beneficiaries. In recent years, the benefit has been cut several times, including a cut of more than 25 percent in 2009 alone.

Across the United States, more than 12 million Americans have been diagnosed with Chronic Obstructive Pulmonary Disease (COPD) and other degenerative lung conditions. COPD is currently the fourth leading cause of death in the United States and is on the rise. As a progressive, incurable disease that causes irreversible loss of lung function, COPD can severely confine patients by limiting their daily living activities. Home oxygen therapy is one of the only effective treatments for these patients when properly used.

About NECA

The National Emphysema/COPD Association empowers people with COPD, their families and caregivers to improve the quality of patient care and the quality of their lives. For more information, visit www.necaweb.org.


'/>"/>
SOURCE National Emphysema/COPD Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Congressmen Mike Ross and Kendrick Meek Introduce Bill to Protect Medicare Patients Who Require Medical Oxygen Therapy at Home
2. National Advocacy Organization Representing Home Oxygen Patients Praises Introduction of Medicare Home Oxygen Therapy Act
3. Oxygen Biotherapeutics, Inc. Announces Private Placement Financing Agreement and Offer to Acquire Warrants
4. Oxygen + MRI might help determine cancer therapy success, researchers find
5. Hummingbird Coaching Partners with Leeza's Place to Help Caregivers “Take Your Oxygen First”
6. Long-term study shows low oxygen levels in prostate tumors can predict recurrence
7. Oxygen Biotherapeutics, Inc. Signs Cooperative Research and Development Agreement With Naval Medical Research Center and Walter Reed Army Institute of Research
8. Oxygen Biotherapeutics, Inc. Files Cosmetic Product Ingredient Statement for new Oxycyte-based Cosmetic Gel
9. Turtle Island Oxygen Trust Sponsors Free Hyperbaric Treatments
10. G & G Holistic Addiction Treatment Uses Innovative Use of Oxygen Therapy Which Restores Mind and Body in Drug Rehab
11. Octi-Flo2™ - 8 Patient Portable Oxygen Delivery System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... As the standards ... a communications platform that positions them as the go-to thought leader in all ... online publication as an always-on, always-fresh news, views and advocacy engine, called ONS ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... at the Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She ... Record, The majority of cases litigated under ERISA involve claims for long-term disability ...
(Date:3/24/2017)... , ... March 24, 2017 , ... Viewers who like ... of critical historical facts, cultural practices, goods, services, and societal issues tend to appreciate ... look into the popular practice of utilizing running events for causes around the world. ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... year of enhancements, upgrading their training and leads programs. , In February, 2017, ... for elite sales agents, Performance Partners is designed to teach how to maximize ...
(Date:3/24/2017)... ... 2017 , ... “Finding Christ Through Social Media: Year One ... the writer’s path toward true communion with God. “Finding Christ Through Social Media: ... creation of published author Lea Michelle Johnson, a follower of Christ, wife and ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , March 24, 2017 A ReportsnReports.com report ... been growing rapidly as the global sales of Adcetris and Kadcyla ... in the antibody drug conjugates market is driven by large number ... and wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 Figures, 10 ...
(Date:3/24/2017)... DIEGO , March 24, 2017  GenomeDx Biosciences ... Resource Information Database) and Decipher® Prostate Cancer Classifier tests ... European Association of Urology (EAU) Congress held March 24 ... . The Annual EAU Congress is Europe,s ... most comprehensive research in the urological field. ...
(Date:3/24/2017)...  Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, www.provectusbio.com ... and dermatology biopharmaceutical company, today disclosed terms of ... (the "Definitive Financing") it entered into on March ... who are referred to in the Definitive Financing ... with the Securities and Exchange Commission.   ...
Breaking Medicine Technology: